BAX and gastric cancer: The lowest overall proliferation rate (Ki-67 immunostaining, Fig. 5b) and the highest pro-apoptotic capacity (cleaved caspase3 and Bax, Fig. 5c) were also observed in the combination group, further validating the improved anticancer efficiency of AZD1775 plus olaparib in mice bearing GC tumors.